Dr. Jacob James Benedict, MD

Dr. Benedict practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Benedict's NPI, 1487185567, was assigned on March 21, 2017. Dr. Benedict graduated from USF Health Morsani College of Medicine in 2017. Dr. Benedict holds Florida license ME154987.

Dr. Benedict's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Benedict's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. Dr. Benedict is also affiliated with Lee Memorial Hospital. The medical group on file is Advocate Radiation Oncology. Dmand AI also links Dr. Benedict to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benedict practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Benedict's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Benedict is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Benedict's licenses on file in 2 states: Florida and Virginia.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Benedict treats.

CMS data shows 1,724 Medicare services from Dr. Benedict across 18 procedure codes in 2024, for 547 Medicare patients. Medicare paid $225,765 for them.

CMS counts 547 Medicare patients who saw Dr. Benedict in 2024. The largest group is 65 to 74, with 258 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Benedict's median patient age at 71, with 49% women.

In 2024, Dr. Benedict wrote 750 Medicare Part D claims for 352 patients. 97% of them were for generic drugs. CMS names the drug for 648 of them, across 12 drugs with 11 or more claims each, at $10,877 in total drug cost. In 2023, CMS named 514 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Benedict for performance year 2024, reported individually. Dr. Benedict accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Benedict, published from 2017 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Melanoma and Proto-Oncogene Proteins B-raf. Dr. Benedict's most frequent co-authors are Vernon K. Sondak, MD, Jonathan S. Zager, MD and Craig S. Derkay, MD.

CMS Open Payments shows 29 general payments to Dr. Benedict from 10 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 98% of the total. Stryker Corporation paid the most, $827.

Dr. Benedict graduated from USF Health Morsani College of Medicine in 2017.

Dr. Benedict is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.